| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
434 |
| issn |
1074-5521 |
| issueIdentifier |
4 |
| pageRange |
433-434 |
| publicationName |
Chemistry & Biology |
| startingPage |
433 |
| bibliographicCitation |
Erdmann J. Targeted therapies for hepatitis C reach the clinic. Chem Biol. 2012 Apr 20;19(4):433–4. doi: 10.1016/j.chembiol.2012.04.005. PMID: 22520745. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_038317345190e1f3a95ad7e5140e8eb1 |
| date |
2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1016/j.chembiol.2012.04.005
https://pubmed.ncbi.nlm.nih.gov/22520745 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20384
https://portal.issn.org/resource/ISSN/1074-5521 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Targeted Therapies for Hepatitis C Reach the Clinic |
| discusses |
http://id.nlm.nih.gov/mesh/M0466818
http://id.nlm.nih.gov/mesh/M0500464
http://id.nlm.nih.gov/mesh/M0017693
http://id.nlm.nih.gov/mesh/M0001518
http://id.nlm.nih.gov/mesh/M0015279 |